Hide metadata

dc.contributor.authorRønneberg, Leiv
dc.contributor.authorKirk, Paul D. W.
dc.contributor.authorZucknick, Manuela
dc.date.accessioned2023-04-25T05:01:45Z
dc.date.available2023-04-25T05:01:45Z
dc.date.issued2023
dc.identifier.citationBMC Bioinformatics. 2023 Apr 21;24(1):161
dc.identifier.urihttp://hdl.handle.net/10852/102021
dc.description.abstractIn this paper we propose PIICM, a probabilistic framework for dose–response prediction in high-throughput drug combination datasets. PIICM utilizes a permutation invariant version of the intrinsic co-regionalization model for multi-output Gaussian process regression, to predict dose–response surfaces in untested drug combination experiments. Coupled with an observation model that incorporates experimental uncertainty, PIICM is able to learn from noisily observed cell-viability measurements in settings where the underlying dose–response experiments are of varying quality, utilize different experimental designs, and the resulting training dataset is sparsely observed. We show that the model can accurately predict dose–response in held out experiments, and the resulting function captures relevant features indicating synergistic interaction between drugs.
dc.language.isoeng
dc.rightsThe Author(s)
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleDose–response prediction for in-vitro drug combination datasets: a probabilistic approach
dc.typeJournal article
dc.date.updated2023-04-25T05:01:46Z
dc.creator.authorRønneberg, Leiv
dc.creator.authorKirk, Paul D. W.
dc.creator.authorZucknick, Manuela
dc.identifier.cristin2158180
dc.identifier.doihttps://doi.org/10.1186/s12859-023-05256-6
dc.type.documentTidsskriftartikkel
dc.type.peerreviewedPeer reviewed
dc.type.versionPublishedVersion
cristin.articleid161


Files in this item

Appears in the following Collection

Hide metadata

Attribution 4.0 International
This item's license is: Attribution 4.0 International